Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CFO Sells 13,512 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 13,512 shares of Aveanna Healthcare stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $97,421.52. Following the completion of the transaction, the chief financial officer directly owned 529,243 shares of the company’s stock, valued at approximately $3,815,842.03. This represents a 2.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Matthew Buckhalter also recently made the following trade(s):

• On Wednesday, February 18th, Matthew Buckhalter sold 13,167 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.38, for a total transaction of $97,172.46.
• On Tuesday, February 17th, Matthew Buckhalter sold 9,351 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.65, for a total transaction of $71,535.15.
• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total transaction of $143,969.00.
• On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $141,424.02.
• On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total transaction of $145,865.28.

Aveanna Healthcare Stock Up 0.3%

Shares of NASDAQ:AVAH traded up $0.02 during trading on Thursday, hitting $7.42. The company’s stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. The business has a 50 day moving average price of $8.48 and a two-hundred day moving average price of $8.44. The company has a market capitalization of $1.55 billion, a PE ratio of 20.61 and a beta of 2.06. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AVAH. UBS Group increased their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, January 15th. Truist Financial upped their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Jefferies Financial Group raised their target price on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a report on Tuesday, October 28th. BMO Capital Markets assumed coverage on shares of Aveanna Healthcare in a report on Thursday, November 13th. They set an “outperform” rating and a $11.00 price target for the company. Finally, William Blair started coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They issued an “outperform” rating on the stock. Five equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Aveanna Healthcare presently has a consensus rating of “Hold” and an average price target of $11.06.

Aveanna Healthcare News Roundup

Here are the key news stories impacting Aveanna Healthcare this week:

• Neutral Sentiment: Short-interest data released for Feb. 19 shows an apparent data anomaly (0 shares reported / NaN change), so there’s no clear short‑interest signal to explain price moves today. (Report notes the short‑interest ratio is effectively 0 days based on reported volume.)
• Neutral Sentiment: Market commentary explains recent intraday weakness in AVAH; see a recent write‑up for context on why the stock moved. Why AVAH is Down
• Negative Sentiment: Significant insider selling: over Feb. 17–19 multiple insiders (CEO Jeff Shaner, several executives including CFO Matthew Buckhalter and CAO Deborah Stewart, plus others such as Edwin C. Reisz and Patrick A. Cunningham) sold large blocks. Combined, these filings show roughly 740,000 shares sold across the group — about $5.4–$5.5M in proceeds — at average prices in the ~$7.20–$7.65 range. Collective, high‑profile sales of this size often weigh on near‑term investor sentiment because they increase supply and may be interpreted as insiders taking money off the table. CEO Filings Other Exec Filings

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare during the second quarter worth about $43,000. MQS Management LLC purchased a new stake in Aveanna Healthcare during the 2nd quarter valued at approximately $59,000. Belvedere Trading LLC purchased a new stake in Aveanna Healthcare during the 2nd quarter valued at approximately $62,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare during the second quarter worth $64,000. Finally, Dynamic Technology Lab Private Ltd acquired a new position in Aveanna Healthcare in the 2nd quarter valued at $68,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.